Overview
Jodie Hay practices practicing medicine in Glasgow, United Kingdom.
Their clinical expertise encompasses RUNX1 Familial Platelet Disorder, Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), and Chronic B-Cell Leukemia (CBCL).
They are actively involved in clinical research, co-authoring 21 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Jodie F. Hay
Is Jodie F. Hay a top-rated expert for RUNX1 Familial Platelet Disorder?
MediFind is an objective health platform that identifies experts based on real-world data. Jodie F. Hay is classified as an Experienced expert for RUNX1 Familial Platelet Disorder, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Jodie F. Hay participate in research or clinical trials?
Yes. Jodie F. Hay has published 21 articles and abstracts on conditions like RUNX1 Familial Platelet Disorder. You can view a list of Jodie F. Hay's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Chronic B-Cell Leukemia (CBCL)
- Chronic Lymphocytic Leukemia (CLL)
- LeukemiaHay isExperienced. Learn about Leukemia.
- RUNX1 Familial Platelet Disorder
- Severe Acute Respiratory Syndrome (SARS)
- Small Lymphocytic Lymphoma (SLL)